Germany
Japan
United Kingdom
China
Lenti ORF particles, IL1RAP (Myc-DDK tagged) - Human interleukin 1 receptor accessory protein (IL1RAP), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
cDNA Clones
Download
Lenti ORF particles, SLC13A2 (Myc-DDK tagged) - Human solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 (SLC13A2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ROR2 (Myc-DDK tagged) - Human receptor tyrosine kinase-like orphan receptor 2 (ROR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLITRK2 (Myc-DDK-tagged)-Human SLIT and NTRK-like family, member 2 (SLITRK2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, PRIMA1 (Myc-DDK tagged) - Human proline rich membrane anchor 1 (PRIMA1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SMPD1 (Myc-DDK tagged) - Human sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MFRP (Myc-DDK tagged) - Human membrane frizzled-related protein (MFRP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ROBO2 (Myc-DDK tagged) - Human roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,584.00
2 Weeks
Lenti ORF particles, CASR (Myc-DDK tagged) - Human calcium-sensing receptor (CASR), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SDC4 (Myc-DDK tagged) - Human syndecan 4 (SDC4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AGER (Myc-DDK tagged) - Human advanced glycosylation end product-specific receptor (AGER), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TIE1 (Myc-DDK tagged) - Human tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LILRB3 (Myc-DDK tagged) - Human leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, LTB4R2 (Myc-DDK tagged) - Human leukotriene B4 receptor 2 (LTB4R2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC3A2 (Myc-DDK tagged) - Human solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (Myc-DDK tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, BEST2 (Myc-DDK tagged) - Human bestrophin 2 (BEST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, BTLA (Myc-DDK tagged) - Human B and T lymphocyte associated (BTLA), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT2 (Myc-DDK tagged) - Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CD70 (Myc-DDK tagged) - Human CD70 molecule (CD70), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, EPCAM (Myc-DDK tagged) - Human epithelial cell adhesion molecule (EPCAM), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,248.00
5 Weeks
Lenti ORF particles, CDH11 (Myc-DDK tagged) - Human cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TNFRSF1A (Myc-DDK tagged) - Human tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PERP (Myc-DDK tagged) - Human PERP, TP53 apoptosis effector (PERP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, PDZK1IP1 (Myc-DDK tagged) - Human PDZK1 interacting protein 1 (PDZK1IP1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, FCGR2B (Myc-DDK tagged) - Human Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, SSTR2 (Myc-DDK tagged) - Human somatostatin receptor 2 (SSTR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, CD300A (Myc-DDK tagged) - Human CD300a molecule (CD300A), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BST2 (Myc-DDK tagged) - Human bone marrow stromal cell antigen 2 (BST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LSAMP (Myc-DDK tagged) - Human limbic system-associated membrane protein (LSAMP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,244.00
3 Weeks
Lenti ORF particles, GPR116 (Myc-DDK-tagged)-Human G protein-coupled receptor 116 (GPR116), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC30A7 (Myc-DDK tagged) - Human solute carrier family 30 (zinc transporter), member 7 (SLC30A7), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, GPRC5D (Myc-DDK tagged) - Human G protein-coupled receptor, family C, group 5, member D (GPRC5D), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, CNR2 (Myc-DDK tagged) - Human cannabinoid receptor 2 (macrophage) (CNR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC7A3 (Myc-DDK tagged) - Human solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 (SLC7A3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, FKBP8 (Myc-DDK tagged) - Human FK506 binding protein 8, 38kDa (FKBP8), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, GPR119 (Myc-DDK tagged) - Human G protein-coupled receptor 119 (GPR119), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
6 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PTGER3 (Myc-DDK-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CDCP1 (Myc-DDK tagged) - Human CUB domain containing protein 1 (CDCP1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
6 Weeks
Lenti ORF particles, SLC18A2 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC7A14 (Myc-DDK tagged) - Human solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 (SLC7A14), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT8 (Myc-DDK tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, KIR3DL3 (Myc-DDK tagged) - Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 (KIR3DL3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,220.00
2 Weeks
Lenti ORF particles, ERBB2 (Myc-DDK tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, GFRAL (Myc-DDK-tagged)-Human GDNF family receptor alpha like (GFRAL), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PDCD1 (Myc-DDK tagged) - Human programmed cell death 1 (PDCD1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MS4A1 (Myc-DDK tagged) - Human membrane-spanning 4-domains, subfamily A, member 1 (MS4A1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CD37 (Myc-DDK tagged) - Human CD37 molecule (CD37), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CD37 (Myc-DDK-tagged)-Human CD37 molecule (CD37), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Category
-
cDNA Clones
- Lentiviral Particles
Tags
- Myc-DDK
Vectors
- pLenti-C-Myc-DDK-P2A-Puro
Mammalian Cell Selection
- Puromycin
Families
- Transmembrane
Brands
- LentiORF
Filter by
Target Symbol
- NRG1 (18)
- BDNF (16)
- CD1E (13)
- DAG1 (13)
- OPRM1 (13)
- ASPH (12)
- CD46 (12)
- FGFR1 (11)
- ST3GAL3 (10)
- ADGRG2 (9)
- CSF2RA (9)
- FCAR (9)
- FGFR2 (9)
- HFE (9)
- MOG (9)
- PTGER3 (9)
- ADGRG1 (8)
- CDH23 (8)
- CHRM2 (8)
- CMTM1 (8)
- FXYD3 (8)
- SLITRK2 (8)
- STRA6 (8)
- TRPM3 (8)
- APP (7)
- ATP2A3 (7)
- CPT1B (7)
- ENTPD1 (7)
- FCRLA (7)
- GABRA1 (7)
- MUC1 (7)
- PROM1 (7)
- PTCH1 (7)
- SIGLEC10 (7)
- SLC11A2 (7)
- TSPAN4 (7)
- ZFYVE27 (7)
- ABCG1 (6)
- ADAM15 (6)
- ARMC10 (6)
- ASTN2 (6)
- BTNL8 (6)
- CLDND1 (6)
- CLEC7A (6)
- HHAT (6)
- HTR4 (6)
- IL1RAP (6)
- IL5RA (6)
- LDLR (6)
- LDLRAD4 (6)
- LST1 (6)
- NIPA2 (6)
- NRP2 (6)
- P2RX2 (6)
- PTPRO (6)
- SEMA6D (6)
- SEZ6L (6)
- SIGLEC6 (6)
- SLC12A6 (6)
- SLC8A3 (6)
- TMEM25 (6)
- TMEM91 (6)
- TNFRSF25 (6)
- TNFSF13 (6)
- TRPC4 (6)
- YIF1B (6)
- ACBD4 (5)
- ADAM22 (5)
- AGTR1 (5)
- AGTRAP (5)
- AIFM1 (5)
- B3GALNT1 (5)
- B3GALT5 (5)
- BLCAP (5)
- BTN2A2 (5)
- CD164 (5)
- CD36 (5)
- CD44 (5)
- CD8B (5)
- CEACAM1 (5)
- CKLF (5)
- CLDN14 (5)
- CLEC2D (5)
- CNR1 (5)
- CUTA (5)
- CYB561D1 (5)
- DPP10 (5)
- EDA (5)
- FCGR2B (5)
- FCGR3A (5)
- FOLH1 (5)
- FXYD6 (5)
- GCNT1 (5)
- GDNF (5)
- GHRL (5)
- GPR137 (5)
- GRAMD3 (5)
- GRIN1 (5)
- ICAM2 (5)
- IGSF1 (5)
Species
Lentivirus
Mutants
Pathways
- Metabolic pathways (503)
- Neuroactive ligand-receptor interaction (392)
- Olfactory transduction (342)
- Cytokine-cytokine receptor interaction (275)
- Cell adhesion molecules (CAMs) (213)
- Calcium signaling pathway (182)
- Hematopoietic cell lineage (146)
- Pathways in cancer (145)
- MAPK signaling pathway (110)
- Regulation of actin cytoskeleton (92)
- Alzheimer's disease (89)
- Jak-STAT signaling pathway (87)
- Natural killer cell mediated cytotoxicity (87)
- Dilated cardiomyopathy (80)
- Endocytosis (77)
- Antigen processing and presentation (71)
- Hypertrophic cardiomyopathy (HCM) (71)
- Lysosome (70)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (69)
- Huntington's disease (69)
- N-Glycan biosynthesis (68)
- ECM-receptor interaction (67)
- Axon guidance (66)
- Oxidative phosphorylation (66)
- Leukocyte transendothelial migration (64)
- Chemokine signaling pathway (63)
- ABC transporters (60)
- Vascular smooth muscle contraction (59)
- Viral myocarditis (59)
- Focal adhesion (57)
- Parkinson's disease (55)
- Drug metabolism - cytochrome P450 (51)
- Adherens junction (49)
- SNARE interactions in vesicular transport (49)
- Retinol metabolism (48)
- Cardiac muscle contraction (46)
- Melanogenesis (46)
- Purine metabolism (45)
- ErbB signaling pathway (44)
- Systemic lupus erythematosus (44)
- Glycerophospholipid metabolism (43)
- PPAR signaling pathway (43)
- Tight junction (43)
- Adipocytokine signaling pathway (42)
- Colorectal cancer (41)
- Glycosphingolipid biosynthesis - lacto and neolacto series (41)
- Graft-versus-host disease (41)
- Metabolism of xenobiotics by cytochrome P450 (41)
- Autoimmune thyroid disease (39)
- Apoptosis (38)
- Sphingolipid metabolism (38)
- Neurotrophin signaling pathway (37)
- O-Glycan biosynthesis (37)
- Prostate cancer (37)
- Wnt signaling pathway (37)
- Basal cell carcinoma (36)
- Gap junction (35)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (35)
- Taste transduction (34)
- Drug metabolism - other enzymes (33)
- Vibrio cholerae infection (33)
- Allograft rejection (32)
- Androgen and estrogen metabolism (32)
- Melanoma (32)
- Type I diabetes mellitus (32)
- Amyotrophic lateral sclerosis (ALS) (31)
- Arachidonic acid metabolism (31)
- Epithelial cell signaling in Helicobacter pylori infection (31)
- Starch and sucrose metabolism (31)
- Toll-like receptor signaling pathway (31)
- Keratan sulfate biosynthesis (30)
- Ether lipid metabolism (29)
- Fc gamma R-mediated phagocytosis (29)
- Porphyrin and chlorophyll metabolism (29)
- Primary immunodeficiency (29)
- Heparan sulfate biosynthesis (28)
- T cell receptor signaling pathway (28)
- TGF-beta signaling pathway (28)
- Complement and coagulation cascades (27)
- Pancreatic cancer (27)
- GnRH signaling pathway (26)
- Fatty acid metabolism (25)
- Hedgehog signaling pathway (25)
- Long-term depression (25)
- Asthma (24)
- Chondroitin sulfate biosynthesis (24)
- Pyrimidine metabolism (24)
- B cell receptor signaling pathway (23)
- Glycerolipid metabolism (23)
- Ascorbate and aldarate metabolism (22)
- Long-term potentiation (22)
- Glycosphingolipid biosynthesis - globo series (21)
- Linoleic acid metabolism (21)
- Pentose and glucuronate interconversions (21)
- p53 signaling pathway (20)
- Glutathione metabolism (19)
- Notch signaling pathway (19)
- Renin-angiotensin system (19)
- Tyrosine metabolism (19)
- Fc epsilon RI signaling pathway (18)
- Glycosphingolipid biosynthesis - ganglio series (17)
- Chronic myeloid leukemia (16)
- Steroid biosynthesis (16)
- Prion diseases (15)
- Small cell lung cancer (15)
- Bladder cancer (14)
- Progesterone-mediated oocyte maturation (13)
- Biosynthesis of unsaturated fatty acids (12)
- Glioma (12)
- Nicotinate and nicotinamide metabolism (12)
- Renal cell carcinoma (12)
- Riboflavin metabolism (12)
- Non-small cell lung cancer (11)
- Oocyte meiosis (11)
- Pathogenic Escherichia coli infection (11)
- Endometrial cancer (10)
- Glycosaminoglycan degradation (10)
- Insulin signaling pathway (10)
- Ubiquitin mediated proteolysis (10)
- Cytosolic DNA-sensing pathway (9)
- Galactose metabolism (9)
- Primary bile acid biosynthesis (9)
- VEGF signaling pathway (9)
- alpha-Linolenic acid metabolism (9)
- Cyanoamino acid metabolism (8)
- Phosphatidylinositol signaling system (8)
- RIG-I-like receptor signaling pathway (8)
- Selenoamino acid metabolism (8)
- Taurine and hypotaurine metabolism (8)
- Type II diabetes mellitus (8)
- Caffeine metabolism (6)
- Inositol phosphate metabolism (6)
- O-Mannosyl glycan biosynthesis (6)
- Phenylalanine metabolism (6)
- Thyroid cancer (6)
- Tryptophan metabolism (6)
- C21-Steroid hormone metabolism (5)
- Glycine (5)
- Glycolysis / Gluconeogenesis (5)
- Nitrogen metabolism (5)
- beta-Alanine metabolism (5)
- serine and threonine metabolism (5)
- Amino sugar and nucleotide sugar metabolism (4)
- Citrate cycle (TCA cycle) (4)
- Dorso-ventral axis formation (4)
- Limonene and pinene degradation (4)
- NOD-like receptor signaling pathway (4)
- Sulfur metabolism (4)
- Acute myeloid leukemia (3)
- Arginine and proline metabolism (3)
- Base excision repair (3)
- Cell cycle (3)
- Histidine metabolism (3)
- Lysine degradation (3)
- Pantothenate and CoA biosynthesis (3)
- Propanoate metabolism (3)
- Protein export (3)
- Valine (3)
- leucine and isoleucine degradation (3)
- Butanoate metabolism (2)
- Fatty acid elongation in mitochondria (2)
- Other glycan degradation (2)
- Pyruvate metabolism (2)
- Terpenoid backbone biosynthesis (2)
- Maturity onset diabetes of the young (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)